TF.16 IFU StarDevice.003.10-EN 2021-01-12
prepared by Pulavskyi A., Kolyesnik O.
8
• Pregnancy;
• With severe somatic pathology;
• Areas of epiphyseal growth zone closure of children;
• For patients who have been treated with hormones - up to 6 weeks before the first procedure;
• Over pacemakers and defibrillators, cochlear implants;
• In the presence of stimulators of bone growth and neurostimulants (brain, spinal cord and other
stimulants of nerves);
• In the area where the implants are installed / were installed, above the surface endoprosthesis and the
metal implants;
• Above the open plate (after laminectomy, splitting of the spine);
• In the eye area;
• In the field of reproductive organs;
• Directly above the carotid artery, the stellate ganglion or a vagus nerve, located in the triangle on the
front of the neck;
1.4
SIDE EFFECTS
The use of the device can cause the following side effects:
• Swelling, redness, bruises;
• Spot haemorrhages;
• Pain;
• Skin infection after previous cortisone therapy.
These side effects usually depart after 5-10 days.
After a course of shock-wave therapy, the pain syndrome can be increased, the chronic process
exacerbated, which depends solely on the strength and intensity of the exposure and the individual
susceptibility of patients.
